Early Feasibility Study for Critical Limb Ischaemia intervention device into US Markets

该项目旨在建立一种新型血管移植物的商业可行性和市场潜力，这种新型血管移植物专门用于改善移植物的耐久性和需要手术干预的严重肢体缺血患者的预后。该移植物将利用Elast-Eon经过验证的生物相容性和非血栓形成性质，以及RUA生命科学集团实体的植入式纺织品专业知识。可行性研究期间将开展的活动是加深与当前美国制造合作伙伴的关系，与最终用户外科医生接触，并确定将新设备分销到美国市场的商业合作伙伴。

The project is designed to establish the commercial viability and potential for market launch of a novel vascular graft specifically designed to improve graft durability and the outcomes for patients requiring surgical intervention for critical limb ischemia. The graft will utilise the proven biocompatibility and non-thrombogenic nature of Elast-Eon together with the implantable textiles expertise of the RUA Life Science group entities. Activities to be undertaken during the feasibility study are to deepen the relationship with a current US based manufacturing partner, engage with end user surgeons and identify commercial partners for distributing the novel device into the US market.